US Patent Litigations are now available. Check here

Explore Nektar Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3134123Feb 17, 2021Il-2Rbeta-Selective Agonists In Combination With An Anti-Ctla-4 Antibody Or An An Anti-Pd-1 Antibody2
EP2453962Mar 14, 2018Negatively Biased Sealed Nebulizers Systems And Methods1
EP3094331Dec 27, 2017Combination-Based Treatment Method1